Good question, i don’t know the answer (this is the first time i used them) but i can find out.
Overall, i feel this space (of Dx testing) is completely commoditized and has low entry barriers. DLCL doesn’t have moat as such. FY22 AR lists all these challenges.
| Subscribe To Our Free Newsletter |
